United States: Federal Circuit Affirms First Patent Trial And Appeal Board (PTAB) Decision In A Covered Business Method Review

Last Updated: July 17 2015
Article by Mark P. Wine and James Maune

​On July 9, 2015, a divided panel of the Court of Appeals for the Federal Circuit ("CAFC") affirmed the first Patent Trial and Appeals Board ("PTAB") decision concerning Covered Business Method ("CBM") reviews, which were created by Section 18 of the Leahy-Smith America Invents Act ("AIA").  Versata Development Group, Inc. v. SAP America, Inc., Case No. 2014-1194.  The PTAB had ruled two years earlier that claims 17 and 26-29 of U.S. Patent No. 6,553,350, assigned to Versata Development Group, Inc., were unpatentable as abstract ideas under 35 U.S.C. § 101.  Versata appealed.

The Federal Circuit decision resolves several important issues related to CBM reviews.  Among other things, the court decided that (1) broadest reasonable interpretation is the proper standard for claim construction in a CBM review; (2) the PTAB may consider § 101 patentability challenges in a CBM review; (3) the CAFC may decide, on appeal from a CBM review, whether the challenged patent is eligible for CBM review; and (4) the CAFC may consider, on appeal from a CBM review, whether the PTAB correctly decided certain other issues implicating the scope of the PTAB's decision-making authority.

Based on these rulings, the CAFC proceeded to consider the merits of the PTAB's determination that the challenged claims of the ʼ350 patent were invalid under § 101, and it affirmed.  Judge Hughes dissented in part, arguing that the CAFC was exceeding its jurisdiction by reviewing whether the challenged patent was eligible for CBM review.

Some Decisions of the PTAB in Instituting a CBM Review Are Reviewable in an Appeal From a Final Written Decision

The panel majority held that the CAFC, when deciding an appeal from a final written decision of the PTAB in a CBM review, has jurisdiction to review issues decided by the PTAB that implicate the scope of the PTAB's authority—even if those issues were only expressly addressed by the PTAB in the context of deciding to institute review.  SAP America and the USPTO, as intervenor, argued that 35 U.S.C. § 324(e) precludes such review because it states that "[t]he determination by the [PTAB] whether to institute a post-grant review under this section shall be final and nonappealable."  The panel majority disagreed, holding that the statute does not preclude appellate review of limits on the PTAB's authority to enter a "'final written decision' invalidating a patent."  The majority explained that "[i]nstitution and invalidation are two distinct actions by the PTAB."  In an appeal from a final written decision, review of an issue affecting the PTAB's authority to invalidate a patent is not precluded "just because the agency chooses, or even follows a congressional directive, to decide an issue determining final-action authority at the initiation stage and then does not revisit the issue later."  Foreclosing review of such PTAB decisions would "run counter to our long tradition of judicial review of government actions that alter the legal rights of an affected person, a hallmark of the distinction between (generally reviewable) final agency action and (generally unreviewable) agency action that merely initiates a process to consider such an alteration."

Judge Hughes disagreed, arguing that the plain language of § 324(e) unambiguously bars judicial review of the PTAB's decision to institute review at any time.  Judge Hughes stated that nothing in that section's language suggests that the judicial review bar is limited, as the majority held, to interlocutory appeals of the PTAB's decision to institute.  He also contended that the majority's interpretation "directly conflicts" with the CAFC's recent decision in In re Cuozzo Speed Technologies, LLC, No. 14-1301 (Fed. Cir. July 8, 2015).

The "Broadest Reasonable Interpretation" Claim Construction Standard Applies

On another matter of procedure, Versata challenged the PTAB's decision to apply the "broadest reasonable interpretation" ("BRI") claim construction standard in a CBM review.  This standard is generally used in USPTO office actions, and the PTAB adopted it for all AIA post-grant proceedings.  Siding with the PTAB, the CAFC deferred to its previous decision in Cuozzo, in which the court approved the PTAB's use of the BRI standard in inter partes reviews ("IPRs").  The CAFC acknowledged that although the rules applicable to IPRs will not necessarily always govern in CBM or other post-grant reviews, the CAFC saw no basis to distinguish between the two proceedings for purposes of the applicable claim construction standard.

The PTAB May Consider § 101 Subject Matter Eligibility Challenges in CBM Reviews

Versata argued that Section 101 of the Patent Act may not be considered as a basis for unpatentability in CBM reviews.  Under Chapter 32 of the Act, governing post-grant review and § 18 cases, the PTAB "shall issue a final written decision with respect to the patentability of any patent claim challenged . . . ."  35 U.S.C. § 328(a) (emphasis added).  This language seemingly gives the PTAB broad authority to consider patentability challenges.  However, Versata pointed out that 35 U.S.C. § 321(b), entitled "Scope," states that a petitioner "may request to cancel as unpatentable 1 or more claims of a patent on any ground that could be raised under paragraph (2) or (3) of section 282(b) (relating to invalidity of the patent or any claim)."  (Emphasis added.)  Versata argued that § 101 challenges do not fall within the scope of paragraph (2) or (3) of Section 282(b), which specifies the defenses that may be raised in a lawsuit involving the validity or infringement of a patent.  The headings in the compiled statutes concerning conditions for patentability only list § 102 (anticipation) and § 103 (obviousness), not § 101 (subject matter eligibility).  Versata accordingly argued that § 321(b) precludes § 101 review.  SAP and USPTO countered that it is generally understood that § 101 is an invalidity defense under § 282, and that Versata's reliance on the headings was improper.

The CAFC rejected Versata's argument.  It noted that both CAFC and Supreme Court opinions over the years have established that § 101 challenges constitute validity and patentability challenges.  Adopting Versata's position would require a hyper-technical adherence to form over substance.  Consequently, the CAFC concluded that the PTAB had acted within the scope of its authority delineated by Congress in permitting a § 101 challenge in a CBM review.


Finally addressing the merits after resolving the numerous procedural and jurisdictional predicate issues summarized above, the CAFC affirmed the PTAB's decisions that:  (1) the '350 patent is a covered business method patent subject to CBM review; (2) the invention claimed in the ʼ350 patent is not a "technological invention" for which CBM review is not available; and (3) the PTAB properly construed the challenged claims of the '350 patent and held those claims invalid under § 101.


The CAFC's Versata decision resolved several important issues related to CBM review.  It authorizes § 101 patentability challenges in such proceedings.  It confirms that the BRI claim construction standard applies—a ruling that is likely to stand for some time given the court's recent denial of a request for en banc review in Cuozzo, in which the BRI standard was found applicable in the IPR context.  And it allows judicial review of PTAB decisions that challenged patents are eligible for CBM review, although only in the context of appeals from final written decisions.  However, the CAFC did not provide any further guidance for determining when a patent is "a covered business method patent" eligible for CBM review, or what defines a "technological invention" that may not be challenged in such a proceeding.  Thus, the opinion is not as helpful as it could have been.

It should be noted that whether Versata's influence is to be long-lived may depend on Congress, which is considering several patent reform bills.  The PATENT Act (S 1137), the Innovation Act (H.R. 9), and the STRONG Patents Act (S 632) all contain provisions that would require that claims in USPTO trial proceedings be construed in the same manner as a court would construe such claims in a civil action, thus scrapping the BRI standard endorsed by Cuozzo and Versata.  The Senate Judiciary Committee approved the PATENT Act by a vote of 16-4 on June 4, 2015.  The House Judiciary Committee approved the Innovation Act by a vote of 24-8 on June 11, 2015.  The STRONG Patents act is currently pending in the Committee on Small Business and Entrepreneurship.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.